Carbidopa, Levodopa And Entacapone Tablet, Film Coated
Product Images NDC 33342-493

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 33342-493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Carton (Cle 100 200mg Carton)

Label for Carbidopa, Levodopa and Entacapone Tablets by Macleods Pharmaceuticals Limited, showing the dosage strengths 25 mg Carbidopa, 100 mg Levodopa, and 200 mg Entacapone per film-coated tablet. The label states the product is an oral prescription drug in unit-dose packaging of 100 tablets (10 x 10). The manufacturer details and storage instructions are included along with barcode and NDC number 33342-493-12.*

FDA Label Image

Cle-100-200mg-container (Cle 100 200mg Container)

Label for Carbidopa, Levodopa and Entacapone Tablets by Macleods Pharmaceuticals Limited. It states each film-coated tablet contains Carbidopa USP 25 mg, Levodopa USP 100 mg, and Entacapone USP 200 mg. The package contains 100 tablets, with storage instructions and manufacturer details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd. Warnings against crushing, splitting, or combining tablets are included.*

FDA Label Image

125 mg Carton (Cle 125 200mg Carton)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated oral tablets containing 31.25 mg Carbidopa, 125 mg Levodopa, and 200 mg Entacapone per tablet. The label indicates a package of 100 unit-dose tablets and is manufactured by Macleods Pharmaceuticals Limited for Macleods Pharma USA, Inc.*

FDA Label Image

Cle-125-200mg-container (Cle 125 200mg Container)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated, containing 31.25 mg Carbidopa, 125 mg Levodopa, and 200 mg Entacapone per tablet. Package contains 100 tablets. Manufactured by Macleods Pharmaceuticals Ltd and labeled for Macleods Pharma USA, Inc. Instructions include swallowing whole without crushing, splitting, or chewing. Storage at 20-25°C with permitted excursions noted.*

FDA Label Image

150 mg Carton (Cle 150 200mg Carton)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated oral tablets containing 37.5 mg Carbidopa, 150 mg Levodopa, and 200 mg Entacapone. The label indicates a package of 100 unit-dose tablets (10 x 10) manufactured by Macleods Pharmaceuticals Limited for Macleods Pharma USA, Inc. It contains storage instructions and a warning against combining tablets to achieve higher strength due to overdose risk.*

FDA Label Image

Cle-150-200mg-container (Cle 150 200mg Container)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated, containing 37.5 mg Carbidopa, 150 mg Levodopa, and 200 mg Entacapone. The package contains 100 tablets. Manufactured by Macleods Pharmaceuticals Limited and labeled for Macleods Pharma USA, Inc. Storage instructions and a warning against crushing or splitting the tablets are included.*

FDA Label Image

200 mg Carton (Cle 200 200mg Carton)

Label for Carbidopa, Levodopa and Entacapone Tablets film-coated, containing Carbidopa 50 mg, Levodopa 200 mg, and Entacapone 200 mg per tablet. The label shows the product name, active ingredient strengths, manufacturer Macleods Pharmaceuticals Limited, and Macleods Pharma USA, Inc. as the labeler. It includes storage instructions, dosage form as oral tablets, and a unit-dose package containing 100 tablets (10 x 10).*

FDA Label Image

Cle-200-200mg-container (Cle 200 200mg Container)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated, containing Carbidopa 50 mg, Levodopa 200 mg, and Entacapone 200 mg per tablet. The label indicates a package of 100 tablets by Macleods Pharma USA, manufactured by Macleods Pharmaceuticals Ltd. with storage and dosage instructions.*

FDA Label Image

50-carton (Cle 50 200mg Carton)

Label for Carbidopa, Levodopa and Entacapone Tablets film-coated tablets, containing 12.5 mg Carbidopa, 50 mg Levodopa, and 200 mg Entacapone per tablet. The label indicates a package size of 100 unit-dose tablets (10 x 10). Manufactured by Macleods Pharmaceuticals Limited for Macleods Pharma USA, Inc.*

FDA Label Image

Cle-50-200mg-container (Cle 50 200mg Container)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated, containing 12.5 mg Carbidopa, 50 mg Levodopa, and 200 mg Entacapone per tablet. The label shows dosage instructions to swallow whole and storage conditions at 20° to 25°C. Manufactured by Macleods Pharmaceuticals Limited and labeled for Macleods Pharma USA, Inc. The package contains 100 tablets.*

FDA Label Image

75 mg Carton (Cle 75 200mg Carton)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated oral tablets with strengths of 18.75 mg Carbidopa, 75 mg Levodopa, and 200 mg Entacapone. Manufactured by Macleods Pharmaceuticals Limited for Macleods Pharma USA, Inc., the package contains 100 unit-dose tablets. The label includes storage instructions and warnings about not combining tablets for higher strength.*

FDA Label Image

Cle-75-200mg-container (Cle 75 200mg Container)

Label for Carbidopa, Levodopa and Entacapone Tablets containing Carbidopa 18.75 mg, Levodopa 75 mg, and Entacapone 200 mg per film-coated tablet. The package holds 100 tablets. Manufactured by Macleods Pharmaceuticals Limited and distributed by Macleods Pharma USA, Inc. The label includes dosage instructions to swallow whole and storage conditions between 20° to 25°C.*

FDA Label Image

Cle-str-carb.jpg (Cle Str Carb)

Chemical structure diagram showing a molecule with a phenol group, a chiral center, a hydrazine functional group, and a carboxylic acid group, along with a water molecule (H2O). The image represents a chemical structure relevant to the product containing Carbidopa, Levodopa and Entacapone.*

FDA Label Image

Cle-str-enta.jpg (Cle Str Enta)

Chemical structure diagram of the active ingredient shown, featuring molecular bonds and functional groups, consistent with typical representations in pharmaceutical labeling.*

FDA Label Image

Cle-str-levo.jpg (Cle Str Levo)

Chemical structure of Carbidopa, Levodopa and Entacapone active ingredients showing the molecular arrangement of atoms including hydroxyl groups and amine functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.